Sector Chart Myriad Genetics, Inc.
Stocks
MYGN
US62855J1043
Medical Equipment, Supplies & Distribution
|
Market Closed -
Nasdaq
06:00:00 02/10/26 am AEST
|
5-day change | 1st Jan Change | ||
| 4.060 USD | -5.80% |
|
-1.93% | -33.98% |
| 16/09 | Myriad Genetics, Inc. Announces Management Changes | CI |
| 09/09 | UBS Adjusts Price Target on Myriad Genetics to $3.60 From $6, Keeps Neutral Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Diagnostic & Testing Substances
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 388M | - | ||||
| 167B | |||||
| 111B | |||||
| 105B | |||||
| 74.82B | |||||
| 59.11B |
- Stock Market
- Stocks
- MYGN Stock
- Charts Myriad Genetics, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
